Results from RT-qPCR and western blotting analyses revealed higher FAM50A expression levels in tumor cell lines than normal FHC cells, at both the mRNA (Fig 6A, upper panel) and protein levels (Fig 6A, lower panel). This evidence concerns the gene FAM50A and neoplasm.